These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33724543)

  • 1. PVP-coated Gd-grafted nanodiamonds as a novel and potentially safer contrast agent for in vivo MRI.
    Panich AM; Salti M; Prager O; Swissa E; Kulvelis YV; Yudina EB; Aleksenskii AE; Goren SD; Vul' AY; Shames AI
    Magn Reson Med; 2021 Aug; 86(2):935-942. PubMed ID: 33724543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining relaxivities in suspensions of nanodiamonds grafted by magnetic entities: comparison of two approaches.
    Panich AM; Shames AI; Goren SD; Yudina EB; Aleksenskii AE; Vul' AY
    MAGMA; 2020 Dec; 33(6):885-888. PubMed ID: 32347397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Characterization, and Magnetic Resonance Evaluation of Polyglycerol-Functionalized Detonation Nanodiamond Conjugated with Gadolinium(III) Complex.
    Zhao L; Shiino A; Qin H; Kimura T; Komatsu N
    J Nanosci Nanotechnol; 2015 Feb; 15(2):1076-82. PubMed ID: 26353615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
    Fries P; Massmann A; Robert P; Corot C; Laschke MW; Schneider G; Buecker A; Müller A
    Invest Radiol; 2019 Sep; 54(9):549-558. PubMed ID: 31033675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated Spin-7/2 Species of Gadolinium (III) Chelate Complexes on the Surface of 5-nm Diamond Particles.
    Osipov VY; Boukhvalov DW; Takai K
    Nanomaterials (Basel); 2023 Jul; 13(13):. PubMed ID: 37446511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study.
    Sasaki M; Shibata E; Kanbara Y; Ehara S
    Magn Reson Med Sci; 2005; 4(3):145-9. PubMed ID: 16462135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging.
    Goetschi S; Froehlich JM; Chuck NC; Curcio R; Runge VM; Andreisek G; Nanz D; Boss A
    Invest Radiol; 2014 Sep; 49(9):608-19. PubMed ID: 24710201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual T
    Xu L; Hong SH; Sun Y; Sun Z; Shou K; Cheng K; Chen H; Huang D; Xu H; Cheng Z
    Nanomedicine; 2018 Aug; 14(6):1743-1752. PubMed ID: 29679743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanodiamond-Gadolinium(III) Aggregates for Tracking Cancer Growth In Vivo at High Field.
    Rammohan N; MacRenaris KW; Moore LK; Parigi G; Mastarone DJ; Manus LM; Lilley LM; Preslar AT; Waters EA; Filicko A; Luchinat C; Ho D; Meade TJ
    Nano Lett; 2016 Dec; 16(12):7551-7564. PubMed ID: 27960515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gd(III)-nanodiamond conjugates for MRI contrast enhancement.
    Manus LM; Mastarone DJ; Waters EA; Zhang XQ; Schultz-Sikma EA; Macrenaris KW; Ho D; Meade TJ
    Nano Lett; 2010 Feb; 10(2):484-9. PubMed ID: 20038088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T1 relaxivities in human blood plasma.
    Noebauer-Huhmann IM; Szomolanyi P; Juras V; Kraff O; Ladd ME; Trattnig S
    Invest Radiol; 2010 Sep; 45(9):554-8. PubMed ID: 20697225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
    Jahanbin T; Sauriat-Dorizon H; Spearman P; Benderbous S; Korri-Youssoufi H
    Mater Sci Eng C Mater Biol Appl; 2015; 52():325-32. PubMed ID: 25953574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New gadolinium complexes as magnetic resonance imaging--contrast agents.
    Wagner M; Ruloff R; Hoyer E; Gründer W
    Z Naturforsch C J Biosci; 1997; 52(7-8):508-15. PubMed ID: 9376038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
    Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
    Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.